Title 22 — Foreign Relations and Intercourse
Part A · Chapter 83 — United States Leadership Against Hiv/aids, Tuberculosis, and Malaria
§ 7636. Study on illegal diversions of prescription drugs
Statutory text
Not later than 180 days after , the Secretary of Health and Human Services, in coordination with other agencies, shall submit a report to the Congress that includes the following:
A thorough accounting of evidence indicating illegal diversion into the United States of prescription drugs donated or sold for humanitarian efforts, and an estimate of the extent of such diversion.
Recommendations to increase the administrative and enforcement powers of the United States to identify, monitor, and prevent the illegal diversion into the United States of prescription drugs donated or sold for humanitarian efforts.
Recommendations and guidelines to advise and provide technical assistance to developing countries on how to implement a program that minimizes diversion into the United States of prescription drugs donated or sold for humanitarian efforts.
Legislative history
Reconstructed from this section’s Code source credit and amendment notes, resolved against the local Statutes at Large. Editorial notes are evidence, not the law that made the change.
United States Leadership Against HIV/AIDS, Tuberculosis, and Malaria Act of 2003
Pub. L. 108–25 title III § 307 · 117 Stat. 711
Enacted · 22 U.S.C. § 7636
(Pub. L. 108–25, title III, § 307, May 27, 2003, 117 Stat. 740.)
Source evidence
Code source credit
(Pub. L. 108–25, title III, § 307, May 27, 2003, 117 Stat. 740.)Enacted provision · exact public law section
SEC. 307. STUDY ON ILLEGAL DIVERSIONS OF PRESCRIPTION DRUGS. Not later than Deadline. Reports. 180 days after enactment of this Act, the Secretary of Health and Human Services, in coordination with other agencies, shall submit a report to the Congress that includes the following: (1) A thorough accounting of evidence indicating illegal diversion into the United States of prescription drugs donated or sold for humanitarian efforts, and an estimate of the extent of such diversion. (2) Recommendations to increase the administrative and enforcement powers of the United States to identify, monitor, and prevent the illegal diversion into the United States of prescription drugs donated or sold for humanitarian efforts. (3) Recommendations and guidelines to advise and provide technical assistance to developing countries on how to implement a program that minimizes diversion into the United States of prescription drugs donated or sold for humanitarian efforts.
1 of 1 references resolved to an enrolled provision